Safety and effectiveness of balloon cryoablation for treatment of Barrett’s associated neoplasia: systematic review and meta-analysis
Authors:
Open Access
- 22 January 2020
- journal article
- review article
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 08 (02) , E172-E178
Abstract
Background and study aims Balloon cryoablation (BC) is a novel procedure for endoscopic ablation of Barrett’s esophagus (BE- associated neoplasia. We performed a meta-analysis to assess the feasibility, effectiveness, and safety of BC for treatment of BE neoplasia. Patients and methods Several databases were searched for relevant articles (PubMed, Web of Science, Google Scholar, EMBASE) as well as abstracts of recent gastroenterology meetings. Data extraction was performed by two investigators using standardized forms, including age, gender, length of BE segment, prior treatments, procedural time and number ablation sessions, technical feasibility, adverse events, and eradication rates of intestinal metaplasia (CE-IM) and dysplasia (CE-D) at follow-up. Quality of the studies was assessed using a modified Newcastle Ottawa Scale. Results Seven studies met inclusion criteria for a total of 548 ablation sessions in 272 patients. The most common histopathology reported prior to BC was high-grade dysplasia (n = 131), followed by low-grade dysplasia (n = 75), and intramucosal adenocarcinoma (n = 52). The pooled rate for technical feasibility was 95.8 % (95 % CI: 93.6–97.5 %; I2 = 13.2 %; P = 0.3). Pooled rates of CE-IM and CE-D were 85.8 % (95 % CI: 77.8–92.2 %, I2 = 55.5 %; p = 0.04) and 93.8 % (95 % CI: 85.5–98.7 %, I2 = 74.2 %; P = 0.001), respectively. The overall adverse event (AE) rate was 12.5 % (34 out of 272 patients), of which stricture formation was the most common (5.8 %), followed by mucosal laceration (0.7 %), perforation (0.4 %), and bleeding (0.4 %). All AEs were successfully managed endoscopically. Conclusion This meta-analysis suggests that BC is a safe and effective ablative technique for treatment of BE neoplasia; future prospective comparative trials are needed to corroborate these initial findings.Keywords
This publication has 29 references indexed in Scilit:
- Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade DysplasiaJAMA, 2014
- Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2013
- A novel device for ablation of abnormal esophageal mucosa (with video)Gastrointestinal Endoscopy, 2011
- Interpretation of random effects meta-analysesBMJ, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort studyGut, 2010
- Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasiaGastrointestinal Endoscopy, 2010
- An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patientsGastrointestinal Endoscopy, 2009
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagusGastrointestinal Endoscopy, 1999